Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets closed
ALL ORDS
7,992.30
-21.50
(-0.27%)
AUD/USD
0.6675
+0.0006
(+0.08%)
ASX 200
7,750.70
-16.80
(-0.22%)
OIL
81.93
+0.39
(+0.48%)
GOLD
2,341.50
+1.90
(+0.08%)
Bitcoin AUD
94,057.76
+2,061.91
(+2.24%)
Chemomab Therapeutics Ltd. (CMMB)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.9124
-0.0406
(-4.26%)
At close: 04:00PM EDT
0.8200
-0.10
(-10.87%)
Pre-market:
06:01AM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Balance sheet
All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
9,292
13,519
15,186
11,674
Other short-term investments
10,492
26,374
45,975
24
Total cash
19,784
39,893
61,161
11,698
Total current assets
20,897
41,736
62,688
11,839
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
921
759
809
653
Accumulated depreciation
-226
-165
-107
-73
Net property, plant and equipment
695
594
702
580
Equity and other investments
-
-
0
4
Other long-term assets
-
-
55
53
Total non-current assets
1,254
1,327
1,665
637
Total assets
22,151
43,063
64,353
12,476
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
516
1,688
1,336
93
Accrued liabilities
3,423
3,378
555
715
Total current liabilities
4,838
6,749
2,650
1,316
Non-current liabilities
Total non-current liabilities
316
91
237
358
Total liabilities
5,154
6,840
2,887
1,674
Stockholders' equity
Common stock
0
0
0
0
Retained earnings
-88,678
-63,819
-36,173
-23,695
Total stockholders' equity
16,997
36,223
61,466
10,802
Total liabilities and stockholders' equity
22,151
43,063
64,353
12,476
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.